The short version of thymosin beta-4 fits in a sentence. The long version — which is the one that helps — is below.
This page was last updated on 2026-08-01 and is reviewed periodically as new material appears.
The compound circulates in the literature as a research reagent rather than an approved therapeutic. Regulatory agencies in several countries have not authorized it for medical use, and sporting bodies list related thymosin beta-4 peptides among prohibited substances. Suppliers typically market it with a purity figure and a certificate of analysis, while peer-reviewed clinical reports remain sparse. Discussions therefore often separate laboratory findings from anecdotal reports, and reviewers tend to note the small size and methodological limits of the available studies.
TB-500 refers to a synthetic peptide fragment derived from the actin-binding region of thymosin beta-4, a protein present in most mammalian cells. The full protein contains forty-three amino acids, while the commonly sold fragment is a much shorter acetylated sequence, often cited as LKKTETQ. The fragment retains part of the actin-binding motif but lacks the remainder of the parent protein. Material sold under this name is usually lyophilized powder intended for laboratory research, and it is not a finished pharmaceutical product.
No major regulatory agency has approved TB-500 for therapeutic use, and it holds no pharmacopoeial monograph. The name appears on the World Anti-Doping Agency prohibited list within the class covering peptide hormones, growth factors, and related substances. Detection in doping control relies on mass spectrometric methods applied to urine, often after preparation steps that concentrate the analyte. Discussion of TB-500 therefore clusters in biochemistry, sports medicine, and anti-doping literature rather than in registered clinical trials.
TB-500 is a synthetic peptide preparation marketed under a name derived from thymosin beta-4, a 43-residue actin-binding protein first isolated from thymus tissue. The full-length protein has a reported molecular mass near 4963 Da, while material sold as TB-500 is often described as a fragment containing the actin-binding motif LKKTETQ. Because suppliers use the name inconsistently, published sources sometimes refer to the same label as a fragment, a synthetic copy, or a related analog. This naming ambiguity complicates direct comparison of reports across studies.
Laboratory work on thymosin beta-4 describes binding to monomeric actin and effects on cell migration, angiogenesis, and inflammatory signaling in cultured cells. Animal models have examined skin, corneal, and cardiac repair after injury, with outcomes reported mainly in preclinical literature. Most of that evidence concerns the parent protein rather than preparations labelled TB-500, so extrapolation from animal findings to a specific commercial product remains uncertain. Whether the two behave identically in living systems has not been established in controlled human studies.
| Property | Value | Notes |
|---|---|---|
| Appearance | White to off-white powder | Lyophilized solid as supplied |
| Water solubility | Soluble | Dissolves in aqueous media |
| Typical storage temperature | -20 °C | Dry powder, desiccated, protected from light |
| Typical analytical method | RP-HPLC with mass spectrometry | Purity from peak area; mass for identity |
| Common synonyms | Tβ4 fragment; thymosin beta-4 fragment | Naming varies by supplier and catalogue |
Controlled human trials of the short fragment are scarce. Much of what appears in review articles is extrapolated from animal models or from studies of the parent protein, and literature searches return a larger body of cardiac and ophthalmic work on thymosin beta-4 than on the abbreviated peptide. Regulatory treatment differs by jurisdiction, and in several countries the material is handled as a research chemical rather than an approved therapeutic. Statements about human benefit should be read as provisional.
Biological interest in this peptide centers on its relationship to actin dynamics. Thymosin beta-4 binds monomeric actin through an LKKTET motif, and a short sequence carrying that motif can compete with other actin-binding proteins in cell-free preparations. Investigators propose that such competition shifts the balance between filament assembly and disassembly, which in turn affects how readily a cell extends protrusions and migrates. Most of the supporting observations come from cultured cells and purified protein systems rather than from intact organisms.
Animal work has examined the peptide in models of cardiac injury, skin wounding, and corneal repair, with reported outcomes covering cell migration, inflammatory cell influx, and tissue remodeling. Several of those experiments used the full-length protein or longer fragments instead of the seven-residue sequence, which makes direct comparison between reports difficult. Results are generally described as tissue-dependent, and effect sizes vary considerably across laboratories. Independent replication is uneven, so the overall picture is incomplete rather than settled.
The regulatory position is broadly consistent across major jurisdictions: no thymosin beta-4 fragment is an approved medicine, and laboratory material is commonly labelled as not intended for human consumption. Anti-doping rules in sport list thymosin beta-4 and its fragments among prohibited peptide hormones. Because these products travel through research-chemical channels rather than pharmaceutical supply chains, quality varies considerably between vendors. Independent testing of identity, purity and sterility is the only dependable check, and a certificate of analysis describes one batch rather than a supplier's whole catalogue.
Lyophilized peptide powder is normally held desiccated at −20 °C, with −80 °C used for longer storage periods. Allowing a sealed vial to reach room temperature before opening is standard practice, because condensation forming on cold powder introduces moisture. Once dissolved, solutions are typically kept cold and shielded from light. Repeated freeze-thaw cycles are avoided because they encourage aggregation and gradual loss of material. These conventions are general to synthetic peptides rather than unique to any one sequence.
Purity and identity are separate measurements and are often confused. Reverse-phase high-performance liquid chromatography, usually with ultraviolet detection near 214 nanometres, reports the share of total peak area belonging to the target compound. Mass spectrometry by electrospray or matrix-assisted laser desorption then checks whether the observed mass matches the expected sequence. Neither measurement alone shows that a vial holds the intended peptide. Peptide content, meaning the fraction of vial mass that is genuine peptide rather than counter-ion, water or residual acid, is reported separately and is frequently lower than the stated purity figure.
Thymosin beta-4 contains 43 amino acids and has a reported molecular mass near 4963 Da. The short fragment most often associated with the TB-500 label, an acetylated chain beginning LKKTETQ, has a reported mass near 889 Da, so the two are easily separated in analytical work. Mass spectrometry and amino acid analysis can confirm which material is present in a given sample. Statements treating TB-500 and thymosin beta-4 as interchangeable are therefore imprecise, even though the two appear together in much of the same literature.
Interest in the compound comes largely from studies of the parent protein, which participates in actin sequestration, cell migration and tissue repair processes. Whether a short fragment reproduces those activities is a separate question that remains open in the published record. Many summaries describe mechanisms by analogy to thymosin beta-4 rather than from direct measurements on the fragment. Claims about activity should be treated as provisional unless a cited study specifies the exact peptide, its purity and the assay used.
TB-500 is a laboratory label applied to a short synthetic peptide that is widely described as a fragment of thymosin beta-4, an actin-binding protein present in most mammalian cells. Suppliers and review articles usually present TB-500 as the N-terminal region of that protein, but the exact sequence attached to the name is not consistent across sources. Some product descriptions list a seven-residue chain; others use the label loosely for the parent protein itself. Because of that variation, any technical discussion of TB-500 needs to state which sequence is meant.
== Detecting proteins == In some applications, it is necessary to measure the total amount of protein present, rather than the levels of one particular protein. In these cases nonspecific protein assays can be used to quantitate the amount of protein in a sample. Common nonspecific protein assays include the Warburg–Christian method, Kjeldahl method, Lowry assay, and Bradford assay. Many of these rely on the spectrophotometric properties of proteins themselves or in complex with various dyes or reagents. For example, the Bradford Assay exploits the absorbance properties of Coomassie brilliant blue G-250 dye. When free of protein, the dye is red but once bound to protein it turns blue. The Kjeldahl method, in contrast, does not use any dye and is instead a titrimetric assay, sensitive to the nitrogen content in the sample, which correlates with protein content. These assays vary widely in sensitivity, specificity to proteins over other compounds in the sample, and cost.
=== Mexico === In Mexico, Whirlpool has 5 manufacturing plants; three facilities in Apodaca, Nuevo León (including Supsa, Plastics Apodaca, and Horizon) producing refrigerators and washing machines, one facility in Celaya, Guanajuato producing stoves, compact refrigerators, and semi-automatic washing machines, and one facility in Ramos Arizpe, Coahuila producing duplex and French-door refrigerators. On July 1, 2026, Whirlpool announced it will close its Supsa refrigerator manufacturing plant in Apodaca, Mexico, by the second quarter of 2027, shifting production to its facility in Ramos Arizpe and other regional sites.
Broad range of healing philosophies, approaches, and therapies that Western (conventional) medicine does not commonly use to promote well-being or treat health conditions. Examples include acupuncture, herbs, etc. Internet Address: http://www.nccih.nih.gov. (NLM) Compliance
In January 2024, Galloway announced that he would stand in the Rochdale by-election the following month, again for the Workers Party of Britain. Galloway claimed he received a text from Richard Tice to be the Reform UK party candidate. He was elected in a political upset after Azhar Ali, the Labour candidate, lost the support of his party due to comments made regarding the Hamas-led attack on Israel. Galloway won almost 40% of the vote and overturned a Labour majority of 9,668. The Gaza war dominated the campaign. In his election speech, Galloway said "Keir Starmer, this is for Gaza. You will pay a high price for the role that you have played in enabling, encouraging and covering for the catastrophe presently going on in occupied Gaza, in the Gaza Strip". Alluding to the size of his win over the Labour and Conservative candidates, he said, "Keir Starmer and Rishi Sunak are two cheeks of the same backside and they both got well and truly spanked tonight here in Rochdale." Galloway chose to make a religious oath rather than a secular affirmation when being sworn into parliament; in which he held a Bible and swore allegiance to King Charles and his heirs upon God. On 23 May 2024, Galloway confirmed he would be running for re-election in Rochdale at the 2024 general election. Galloway polled 11,508 votes and lost the seat to Labour's Paul Waugh, who polled 13,047 votes. Galloway did not attend the vote count. He was MP for Rochdale for 92 days.
In December 2022, Bukele tweeted that he believed that the country's 262 municipalities should be reduced to 50. He called it "absurd" ("absurdo") that El Salvador, around 8,100 square miles (21,000 km2) in size, had so many municipalities. Some lawyers and politicians criticized Bukele's proposed reduction as an attempt to consolidate power by gerrymandering. His allies supported the proposal, with some proposing a reduction in the number of Legislative Assembly seats. On 1 June 2023, during a speech commemorating his fourth year in office, Bukele announced that he would present two proposals to the Legislative Assembly. One sought to reduce the number of seats in the assembly from 84 to 60, and the other sought to reduce the number of municipalities from 262 to 44. Bukele justified the legislative reduction by saying that the legislature had 60 seats before the signing of the Chapultepec Peace Accords in 1992 that ended the Salvadoran Civil War, and the accords' only accomplishment was the addition of 24 seats to the legislature. About the municipal-reduction proposal, he stated that the 262 municipalities would retain their cultural identities and be classified as districts. The Legislative Assembly approved the proposal for legislative reductions on 7 June 2023, and approved the proposal for municipal reductions six days later. Both reductions became effective on 1 May 2024.
Sources: en.wikipedia.org
February 24 Meta agrees to purchase millions of artificial intelligence chips from AMD, with AMD committing to supply up to six gigawatts of graphics processing units and issuing Meta warrants convertible into 160 million shares as part of a long-term partnership. Trump delivers the first official State of the Union Address of his second term to a joint session of Congress. February 25 – 2026 Cuban boat incident: Cuban border guards are involved in a shoot-out with ten people on board a US-registered boat. Five of the boat's passengers are killed, and five are injured. February 26 – The Kansas Legislature suspends the driver licenses of all transgender residents, overriding a veto from Governor Laura Kelly. February 27 An extra-governmental group is reportedly working with the Trump administration to draft an executive order which would declare a national emergency and give the Trump administration extended powers over the administration of the 2026 United States elections. Trump denies his knowledge of the existence of such an executive order. Anthropic rejects a Pentagon request to loosen security safeguards on the Claude large language model for potential use in mass surveillance and autonomous weapons systems. In response, Trump orders federal agencies to stop using Anthropic's technology, and OpenAI signs a deal with the Department of Defense. February 28 Iran war: The U.S. and Israel launch attacks on cities in Iran, and assassinate Iran's Supreme Leader Ali Khamenei. Iran launches retaliatory strikes against U.S.
=== Francium halides === Francium halides are all soluble in water and are expected to be white solids. They are expected to be produced by the reaction of the corresponding halogens. For example, francium chloride would be produced by the reaction of francium and chlorine. Francium chloride has been studied as a pathway to separate francium from other elements, by using the high vapour pressure of the compound, although francium fluoride would have a higher vapour pressure.
=== Neurological and neurodegenerative disorders === There has been extensive research into the potential neuroprotective effects of metformin in developmental and neurodegenerative diseases, including Alzheimer's disease and other dementias, Parkinson's disease, Huntington's disease, certain types of epilepsy, and fragile X syndrome, with mixed results. Preliminary studies have examined whether metformin can reduce the risk of Alzheimer's disease and whether there is a correlation between type 2 diabetes and the risk of Alzheimer's disease. While metformin may reduce body weight in persons with fragile X syndrome, whether it improves neurological or psychiatric symptoms is uncertain.
The public's lack of understanding regarding nicotine's biological effects frequently results in inaccurate claims disseminated by the media and general public. In some anti-smoking literature, the harm that tobacco smoking and nicotine addiction does is personified as Nick O'Teen, represented as a humanoid with some aspect of a cigarette or cigarette butt about him or his clothes and hat. Nick O'Teen was a villain that was created for the Health Education Council. The character was featured in three animated anti-smoking public service announcements in which he tries to get kids addicted to cigarettes before being foiled by the DC Comics character Superman. Nicotine was often compared to caffeine in advertisements in the 1980s by the tobacco industry, and later in the 2010s by the electronic cigarettes industry, in an effort to reduce the stigmatization and the public perception of the risks associated with nicotine use.
The magnitude of sensory impairment may vary in people of differing weights. The NIAAA defines the term "binge drinking" as a pattern of drinking that brings a person's blood alcohol concentration (BAC) to 0.08 grams percent or above.
Sources: en.wikipedia.org
TB-500 is a name used for a short synthetic peptide fragment taken from the actin-binding region of thymosin beta-4. Material sold under this label is usually a lyophilized powder supplied for laboratory research rather than a licensed medicine. The commonly cited sequence is LKKTETQ.
The parent protein contains forty-three amino acids, while the fragment carries only a short motif from one region. The fragment can interact with actin in vitro, but it does not include the rest of the protein structure. Whether the shorter molecule behaves the same way in living systems is not settled.
Published controlled human studies are scarce, and most activity reports come from cell culture or animal models. Reviews often describe the evidence base as limited and methodologically uneven. Open questions include the relationship between route, dose, and measured outcomes.
Not necessarily. TB-500 is a commercial label that suppliers apply to synthetic peptides described as thymosin beta-4 or a fragment of it. Published research most often studies the full-length protein, so statements about one do not automatically transfer to the other.